Purpura, Thrombocytopaenic, Idiopathic Clinical Trial
Official title:
An Open-label Repeat Dosing Study of Eltrombopag Olamine (SB-497115-GR) in Adult Subjects, With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
This open-label, repeat dosing study, TRA108057, will evaluate the efficacy, safety and
tolerability of eltrombopag, when administered in a repeat, cyclic dosing schedule. The
study will describe the effect of repeated (3 cycles), intermittent dosing of eltrombopag on
the pharmacodynamics and durability of eltrombopag response as measured by the peripheral
platelet counts.
For more information or to see if you qualify, please visit: http://www.itpstudy.com/gov
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00908037 -
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
|
Phase 2 | |
| Completed |
NCT00442871 -
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
|
Phase 1 | |
| Completed |
NCT01098487 -
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
|
Phase 4 | |
| Withdrawn |
NCT01440361 -
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
|
Phase 2 | |
| Completed |
NCT01064336 -
Promacta Pregnancy Registry
|
N/A | |
| Completed |
NCT00351468 -
EXTEND (Eltrombopag Extended Dosing Study)
|
Phase 3 | |
| Completed |
NCT00688272 -
Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag
|
Phase 1 | |
| Completed |
NCT01072162 -
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect
|
Phase 1 | |
| Completed |
NCT00643929 -
LENS - Long-term Eltrombopag Observational Study
|
N/A | |
| Completed |
NCT00102739 -
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
|
Phase 2 | |
| Completed |
NCT01416311 -
Drug Use Investigation for REVOLADE (ITP)
|
||
| Completed |
NCT00359463 -
Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment
|
Phase 1 |